Aetion, a real-world evidence firm, is partnering with the FDA to utilize real-world data to analyze and understand COVID-19, focusing on patient populations, treatments, diagnostic patterns, and interventions, recognizing the urgency of the situation and highlighting the need for such data amidst the proliferation of COVID-19 treatments and vaccines.
Read More
Read More